RETRACTED ARTICLE: Agmatine protects retinal ganglion cells from hypoxia-induced apoptosis in transformed rat retinal ganglion cell line
Open Access
- 2 October 2007
- journal article
- retracted article
- Published by Springer Nature in BMC Neuroscience
- Vol. 8 (1) , 81
Abstract
Background: Agmatine is an endogenous polyamine formed by the decarboxylation of L-arginine. We investigated the protective effects of agmatine against hypoxia-induced apoptosis of immortalized rat retinal ganglion cells (RGC-5). RGC-5 cells were cultured in a closed hypoxic chamber (5% O2) with or without agmatine. Cell viability was determined by lactate dehydrogenase (LDH) assay and apoptosis was examined by annexin V and caspase-3 assays. Expression and phosphorylation of mitogen-activated protein kinases (MAPKs; JNK, ERK p44/42, and p38) and nuclear factor-kappa B (NF-κB) were investigated by Western immunoblot analysis. The effects of agmatine were compared to those of brain-derived neurotrophic factor (BDNF), a well-known protective neurotrophin for retinal ganglion cells.Results: After 48 hours of hypoxic culture, the LDH assay showed 52.3% cell loss, which was reduced to 25.6% and 30.1% when agmatine and BDNF were administered, respectively. This observed cell loss was due to apoptotic cell death, as established by annexin V and caspase-3 assays. Although total expression of MAPKs and NF-κB was not influenced by hypoxic injury, phosphorylation of these two proteins was increased. Agmatine reduced phosphorylation of JNK and NF-κB, while BDNF suppressed phosphorylation of ERK and p38.Conclusion: Our results show that agmatine has neuroprotective effects against hypoxia-induced retinal ganglion cell damage in RGC-5 cells and that its effects may act through the JNK and NF-κB signaling pathways. Our data suggest that agmatine may lead to a novel therapeutic strategy to reduce retinal ganglion cell injury related to hypoxia.Keywords
This publication has 58 references indexed in Scilit:
- A Glaucoma-Associated Mutant of Optineurin Selectively Induces Death of Retinal Ganglion Cells Which Is Inhibited by AntioxidantsInvestigative Ophthalmology & Visual Science, 2007
- Retinal ganglion cell line apoptosis induced by hydrostatic pressureBrain Research, 2006
- Histamine protects against NMDA‐induced necrosis in cultured cortical neurons through H2 receptor/cyclic AMP/protein kinase A and H3 receptor/GABA release pathwaysJournal of Neurochemistry, 2006
- Neuroprotective effects of agmatine against cell damage caused by glucocorticoids in cultured rat hippocampal neuronsNeuroscience, 2006
- Efficacy and Safety of Memantine Treatment for Reduction of Changes Associated with Experimental Glaucoma in Monkey, II: Structural MeasuresInvestigative Ophthalmology & Visual Science, 2004
- Metabolism and function in animal tissues of agmatine, a biogenic amine formed from arginineAmino Acids, 2003
- Optimal NFκB Mediated Transcriptional Responses in Jurkat T Cells Exposed to Oxidative Stress Are Dependent on Intracellular Glutathione and Costimulatory SignalsBiochemical and Biophysical Research Communications, 1996
- Activation of NF‐κB by ER stress requires both Ca2+ and reactive oxygen intermediates as messengersFEBS Letters, 1996
- Agmatine treatment is neuroprotective in rodent brain injury modelsLife Sciences, 1995
- Agmatine, a novel hypothalamic amine, stimulates pituitary luteinizing hormone release in vivo and hypothalamic luteinizing hormone-releasing hormone release in vitroNeuroscience Letters, 1995